Pfizer's Ringaskiddy site to support global production of pill that cuts risk of severe Covid by 89%
An aerial view of the Pfizer site in Ringaskiddy, Co Cork. File Picture
Pfizer has announced that its facility in Ringaskiddy, Cork will play a key role in supporting the global manufacturing of its new experimental antiviral pill for Covid-19.
A trial of the antiviral pill was stopped early after it was shown to cut the risk of hospitalisation and death in adults at risk of developing severe illness from the virus by 89%.
